Bortezomib will raise the amount or impact of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Improved flibanserin adverse consequences may come about if coadministered with several weak CYP3A4 inhibitors. Other effects, such as a pores and skin rash, is probably not severe but may possibly https://georgeu000isd2.dailyblogzz.com/profile